Abstract:Glucose arguably is the most important energy carrier, carbon source for metabolites and building block for biopolymers in all kingdoms of life. The proper function of animal organs and tissues depends on the continuous supply of glucose from the bloodstream. Most animals can resorb only a small number of monosaccharides, mostly glucose, galactose and fructose, while all other sugars oligosaccharides and dietary fibers are degraded and metabolized by the microbiota of the lower intestine. Bacteria, in contrast, are omnivorous. They can import and metabolize structurally different sugars and, as a consortium of different species, utilize almost any sugar, sugar derivative and oligosaccharide occurring in nature. Bacteria have membrane transport systems for the uptake of sugars against steep concentration gradients energized by ATP, the proton motive force and the high energy glycolytic intermediate phosphoenolpyruvate (PEP). Different uptake mechanisms and the broad range of overlapping substrate specificities allow bacteria to quickly adapt to and colonize changing environments. Here, we review the structures and mechanisms of bacterial representatives of (i) ATP-dependent cassette (ABC) transporters, (ii) major facilitator (MFS) superfamily proton symporters, (iii) sodium solute symporters (SSS) and (iv) enzyme II integral membrane subunits of the bacterial PEP-dependent phosphotransferase system (PTS). We give a short overview on the distribution of transporter genes and their phylogenetic relationship in different bacterial species. Some sugar transporters are hijacked for import of bacteriophage DNA and antibacterial toxins (bacteriocins) and they facilitate the penetration of polar antibiotics. Finally, we describe how the expression and activity of certain sugar transporters are controlled in response to the availability of sugars and how the presence and uptake of sugars may affect pathogenicity and host-microbiota interactions.

A transporter on the move

Glucose transporters in brain in health and disease

Glucose transporters in adipose tissue, liver, and skeletal muscle in metabolic health and disease

Glucose Transporter 1, Distribution in the Brain and in Neural Disorders: Its Relationship with Transport of Neuroactive Drugs Through the Blood-Brain Barrier

Glucose Transporters at the Blood-Brain Barrier: Function, Regulation and Gateways for Drug Delivery

Transporters of glucose and other carbohydrates in bacteria

Transcellular Barriers to Glucose Delivery in the Body

Plant glucose transporter structure and function

GLUT, SGLT, and SWEET: Structural and Mechanistic Investigations of the Glucose Transporters

A Glimpse of Membrane Transport Through Structures—Advances in the Structural Biology of the GLUT Glucose Transporters

Glucose transporters in the small intestine in health and disease

Facilitative glucose transporters:expression,distribution and the relationship to diseases

Relevance of Sugar Transport across the Cell Membrane

Structure and mechanism of a phosphotransferase system glucose transporter

Relationship of Glucose Transporter 1 and Malignant Tumor: an Advance

Bridging the gap: glucose transporters, Alzheimer's, and future therapeutic prospects

Cell transporter protein and engineered applications

Mechanistic Study of Human Glucose Transport Mediated by GLUT1

Transporter effects on cell permeability in drug delivery

ABC transporters: human disease and pharmacotherapeutic potential

Erythrocyte/HEPG2-type glucose transporter is concentrated in cells of blood-tissue barriers